Co-located Warneford clinical and research facilities
The National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre (OH BRC) is run in partnership with Oxford Health NHS Foundation Trust, the University of Oxford and involves 11 additional partner university and NHS Trusts across England.
Through these partnerships, we will establish a national network of centres of excellence for brain health with shared goals, increasing the diversity of patients and populations participating in research and sharing translational infrastructure. This network will build on, and formalise, existing NHS collaborations delivering substantial added value.
We are co-located with clinical facilities on our main Warneford Hospital site, which means we can translate important results straight into the clinic. This central hub is the heart of the network which reaches out to world-class facilities within walking distance, such as the Big Data Institute, the Oxford Centre for Anxiety Disorders and Trauma, and beyond to national and global collaborators through StemBANCC and The Structural Genomics Consortium.
Our patients and the public deserve the same research excellence as in other areas of healthcare, and they will continue to help inform our research at each key step underpinning all our activity. The BRC will have a specific focus on ethnicity and diversity with the aim of improving patient participation in our research and its relevance to the population we serve. Ethnicity and diversity in our research is vital and one of the key reasons for reaching out to partners in other centres across the country.
Find out how you can get involved in our research here.
Our long- term vision is of a UK collaborating network integrating research infrastructure and clinical services to deliver innovation in mental, cognitive and brain health research and care. Our aim for this BRC is to create a platform, working together with partners across the country, to deliver high quality experimental medicine research on new treatments and procedures – to improve lives.
We will continue to harness digital and new technologies so that our solutions can have global reach.
